The surplus fixed income picture could get more challenging in the near term — spread levels are not pricing in a traditional recession on a look-back basis, so valuations aren’t providing much of a cushion. As mentioned previously, I think insurers with existing allocations to bank loans, high-yield bonds, and emerging market debt may want to look to go up in quality within those mandates and favor BBB (within EMD), BB, and B issuers, all else equal. I also think insurers should consider maintaining dry powder, as there may be opportunities to add exposure on weakness in light of the more positive starting point for yields, which are typically a strong determinant of long-term returns.
Equities: Some positive signs, but keeping our guard up
I have raised my view on global equities to moderately underweight but maintain a defensive tilt. I think the lower interest-rate sensitivity of consumers and businesses, and the overall strength of the consumer, make a US hard landing less likely. However, I still believe the distribution of risks for the global economy, and even the US, is skewed to the downside. While the effects of tighter policy are playing out with more of a lag than in the past, there will eventually be a monetary overhang, which implies lower equity valuations and downgrades in earnings expectations.
I think the fiscal impulse that has propped up the private sector will in time become a drag on growth in the US and Europe as they consolidate fiscally — although the impact may be less noticeable in Europe, where fiscal stimulus has not been fully deployed on the ground. I also expect higher inflation risk globally as the path to further disinflation becomes more fraught. A worsening growth/inflation mix will chip away at margins. Meanwhile, global equity valuations are still expensive, in absolute terms and relative to cash. I observe more regional divergence, with the US and Japan outperforming Europe cyclically, and valuations similarly disparate.
I maintain an overweight view on Japanese equities. While the market is no longer cheap, positive economic momentum has fed through to higher margins and earnings growth. The BOJ’s decision to add flexibility to its yield curve control policy in July has not challenged the market’s outperformance, partly because the yen has continued to weaken against the US dollar. In addition, Japanese equities continue to show good market breadth.
I have an underweight view on US and European equities relative to Japan. I have upgraded my US market view slightly, taking into account the resilience of the economy and companies’ exposure to AI trends. But US valuations seem priced for perfection, making them vulnerable to a downgrade in growth expectations sparked by the resumption of student loan repayments, auto worker strikes, or any number of other catalysts. Corporate balance sheets still look solid, although I see some signs of weakening in net margins and interest coverage.
European valuations are attractive and I have more conviction that the European Central Bank has reached the end of its hiking path as the economy has cooled. However, weak earnings momentum and downward adjustments in profitability — in what I believe to be a stagflationary base case — leave me downbeat on equity market prospects. I also see cracks emerging in the services sector, a negative sign for the labor market and consumer resilience.
I have downgraded my China view to neutral, as I have been too optimistic on the potential for a cyclical uplift as well as on structural issues holding back sentiment and investors’ willingness to engage. I am tracking a raft of recent policy measures and signs of cyclical green shoots suggesting we may be at peak pessimism, but also note that there are fewer signs of a turnaround in consumer sentiment or the property cycle. The case for emerging markets ex-China is also finely balanced, with domestic monetary policy easing juxtaposed against a strong US dollar and inflation risks from food and oil.
Regarding sectors, I am positive on financials and negative on materials. I expect financials to be supported by strong corporate fundamentals as well as continued positive sentiment, while I expect the materials sector to struggle given weaker return on equity and higher return volatility.
Commodities: Becoming an essential part of portfolio construction
I’ve previously acknowledged the difficulties insurers have had historically when considering an allocation to commodities, but moving forward, I believe this asset class needs to be strongly considered by insurers of all types. Not only have we seen commodities perform well in 2022 and 2023 year to date, but we have also seen the negative impact inflation has had on claims/underwriting with insurers through the first half of 2023. Generally speaking, insurers are positioned best for periods of rising or falling growth and falling inflation (Figure 3). Very rarely are insurers invested in assets with the potential to outperform in times of rising inflation or stagflation. As cycles become shorter and more volatile, I think having coverage across all economic regimes will be essential.
I continue to have a moderately overweight view on commodities, driven by positive views on copper and gold. In the copper market, I expect favorable long-term supply dynamics and robust demand spurred by spending on the global energy transition. While I continue to monitor the challenging macro environment in China and its impact on copper demand, there have been signs of sustained demand strength, particularly from the housing market.